Fas/APO-1 (CD95) expression in myelodysplastic syndromes

Leukemia and Lymphoma

Volumn 30, Issue 3-4, 1998, Pages 307-312

  Lepelley, Pascale ^a   Grardel, Nathalie ^a   Erny, Olivier ^a   Iaru, Tatiana ^a   Obein, Valérie ^a   Cosson, Alain ^a   Fenaux, Pierre ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Apoptosis; CD 95; Fas; Myelodysplastic syndromes

Indexed keywords

CELL SURFACE PROTEIN; FAS ANTIGEN;

APOPTOSIS; ARTICLE; BLAST CELL; BONE MARROW CELL; CONTROLLED STUDY; ERYTHROBLAST; GRANULOCYTE; HUMAN; IMMUNOCYTOCHEMISTRY; MYELODYSPLASTIC SYNDROME; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0031845360     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057543     Document Type: Article

References (15)

1. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1982). Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology, 51, 189-199.
2. Morel, P., Hebbar, M., Lai, J. L., Duhamel, A., Preudhomme, C., Wattel, E., Bauters, F. and Fenaux, P. (1993). Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system/a report on 408 cases. Leukemia, 7, 1315-23.
3. Raza, A., Gezer, S., Mundle, S., Gao, X. F., Alvi, S., Borok, R., Rifkin, S., Iftikhar, A., Shetty, V., Parcharidou, A., Loew, J., Marcus, R., Khan, Z., Chancy, C., Showel, J., Gregory, S. and Presley, H. (1995). Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes, Blood. 86, 268-276.
4. Lepelley, P., Campergue, L., Preudhomme, C., Grardel, N., Cosson, A. and Fenaux, P. (1996). Is apoptosis a massive process in myelodysplastic syndromes? British Journal of Haematology, 95, 368-371.
5. Bogdanovic, A. D., Jankovic, G. M., Colovic, M. D., Trpinac, D. P. and Bumbasierevic, V. Z. (1996). Apoptosis in bone marrow of myelodysplastic syndrome patients. Blood, 87, 3064.
6. Rajapaksa, R., Ginzton, N., Rott, L. S., Greenberg, P. L. (1996). Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cells, Blood, 88, 4275-4287.
7. Oehm, A., Berhmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Weber, M. L., Richards, S., Dhein, J., Trauth, B. C., Ponstingl, H. and Krammer, P. H. (1992). Purification and molecular cloning of the APO1 cell surface antigen, a member of the TNF/NGF receptor superfamily. Journal of Biological Chemistry, 267, 10709-715.
8. Suda, T., Takahashi, T., Golstein, P. and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the Tumor Necrosis factor family. Cell, 75, 1169-1178.
9. Nagata, S. and Goldstein, P. (1995) The Fas death factor. Science, 267, 1449-1455.
10. Gersuk, G. M., Lee, J. W., Beckman, C. A., Anderson, J. and Deeg, H. J. (1996). Fas (CD95) receptor and Fas ligand expression in bone marrow cell from patients with myelodysplastic syndrome. Blood, 88, 1122-1126.
11. Lepelley, P., Preudhomme, C., Vanrumbeke, M., Quesnel, B., Cosson, A. and Fenaux, P. (1994). Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis. Leukemia, 8, 1342-1349.
12. Lepelley, P., Soenen, V., Preudhomme, C., Merlat, A., Cosson, A. and Fenaux, P. (1995). Bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis. Leukemia, 9, 725-730.
13. + human marrow cells is induced by Interferon γ and Tumor Necrosis Factor α and potentiates cytokine-mediated hematopoietic suppression in vitro. Blood, 85, 3183-3190.
14. Verhoef, G., De Schouwer, P., Ceuppens, J., Vandamme, J., Goossens, W. and Boogaert, M. (1992). Measurement of serum cytokine levels in Patients with myelodysplastic syndromes. Leukemia, 2, 1268-1272.
15. Shetty, V., Mundle, S., Alvi, S., Showel, M., Broady-Robinson, L. T., Dar, S., Borok, R., Showel, J., Gregory, S., Rifkin, S., Gezer, S., Parcharidou, A., Venugopal, P., Shah, R., Hernandez, B., Klein, M., Alston, D., Robin, E., Dominquez, C. and Raza, A. (1996). Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leukemia, 20, 891-900.